RALEIGH – Baseline Controls, a provider of engineering services, has been acquired by Precision for Medicine, a Maryland-based company focused on clinical research, helping companies  bring products to market.

Financial terms weren’t disclosed.

Precision for Medicine is a global firm with 40 offices worldwide.

In a statement, Adam Barlow, Principal and President of Baseline Controls, said: “We see this is an excellent fit for Baseline Controls, bringing us one step closer to achieving our vision of creating a project controls center of excellence for our clients. I look forward to joining the Project Farma leadership team as we combine our unique offerings to support our life sciences clients, from ideation to commercialization.”

Founded in 2010, the company has fewer than 50 employees, according to its LinkedIn site.

Here’s how Baseline Controls describes its business: “At Baseline Controls, we won’t simply build you a schedule with planning software. We build and execute project schedules by performing critical path analyses to identify which tasks need to happen and when. Then, we work to make sure those tasks are accomplished as planned. Anyone can build a project schedule. The difference at Baseline Controls is that we know how to match projects to schedules, and tasks to actions. When we put an action into a schedule, we understand what that means, and that’s the kind of knowledge that only comes from years of experience.”

The Raleigh firm will become part of Precision for Medicine’s “Project Farma” team, te companies said.

Project Farma represents Precision for Medicine’s “existing biomanufacturing strategy and execution group, expanding the scope of its manufacturing solutions for life science companies and driving greater speed and efficiency in bringing new drugs to market,” the Maryland company said